Fermion

Espoo, Finland
Hybrid — also manufactures internal programs
Small Molecule API High-Potency APIs Cytotoxics Oral Solid Dose Sterile Injectables Semi-solids & Liquids
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (10) ○ Clinical Trials ○ SEC Filings ○ Press ✓ EMA GMP (3) ○ MHRA GMP ✓ HC GMP (11)

Quick Facts: Fermion

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Espoo, Finland
Website
Modalities
Small Molecule API, High-Potency APIs, Cytotoxics, Oral Solid Dose, Sterile Injectables, Semi-solids & Liquids
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Fermion

Fermion makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, High-Potency APIs, Cytotoxics, Oral Solid Dose, Sterile Injectables, Semi-solids & Liquids. 4 manufacturing sites registered with the U.S. FDA and Health Canada: its own API plants in Hanko and Oulu, and the drug-product plants of its parent Orion Corporation in Espoo and Turku, whose contract manufacturing Fermion markets. Website: https://www.fermion.fi/cdmo-api/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Fermion FDA Inspection History

2026-02
2024-11
2024-04
2024-03
2023-11
2023-10
2023-03
2023-01
2022-06
2022-03
NAI VAI OAI
Date Site Type Observations Classification
2026-02-25
Fermion Oy
Espoo Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
2024-11-07
Orion Corporation, Orion Pharma
Espoo Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
2024-04-25
Orion Corporation, Orion Pharma
Turku Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
2024-03-14
Fermion Oy
Hanko Pohjoinen Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
2023-11-24
Fermion Oy
Espoo Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
2023-10-25
Orion Corporation, Orion Pharma
Salo Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
2023-03-17
Fermion Oy
Hanko Pohjoinen Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
2023-01-31
Fermion OY
Oulu Company-level
Drug Quality Assurance No No Action Indicated (NAI)
2022-06-02
Orion Corporation, Orion Pharma
Espoo Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
2022-03-10
Orion Corporation, Orion Pharma
Turku Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Fermion EMA GMP Compliance 3 certificates

2026-03
2026-02
2024-03
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
FIMEA/2026/000456 Fermion Oy Finland 2026-03-18 COMPLIANT
FIMEA/2026/000275 Fermion Oy Finland 2026-02-25 COMPLIANT
FIMEA/2024/000416 Fermion Oy Finland 2024-03-14 COMPLIANT
Source: EMA EudraGMDP · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Frequently Asked Questions About Fermion

How many FDA inspections does Fermion have on record?
CDMO Signal tracks 10 FDA inspections for Fermion, sourced from the FDA inspection database. See the full inspection history above.
Has Fermion received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Fermion.
Does Fermion hold EMA or MHRA GMP certificates?
CDMO Signal tracks 3 EMA GMP certificates for Fermion.
Does Fermion have a CDMO Signal Score?
Not yet. Fermion is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Fermion for a manufacturing program?
Use the free AI matchmaker to compare Fermion against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Bayer Contract Manufacturing
Leverkusen, Germany
Oral Solid Dose, Non-sterile Liquids, Semi-solids & Liquids, Sterile Injectables, Lyophilization, Prefilled Syringes, Small Molecule API, High-Potency APIs, Microbial Fermentation
Pierre Fabre CDMO
Castres, France
Oral Solid Dose, Finished Dosage Forms, Non-sterile Liquids, Semi-solids & Liquids, Small Molecule API, High-Potency APIs, Packaging & Labeling
NerPharMa
Nerviano (Milan), Italy
High-Potency APIs, Oncology Products, Small Molecule API, Sterile Injectables, Oral Solid Dose, Biologics
Grindeks
Riga, Latvia
Small Molecule API, Oral Solid Dose, Semi-solids & Liquids, Non-sterile Liquids, Sterile Injectables
Gensenta (formerly Mustafa Nevzat)
Istanbul, Turkey
Sterile Injectables, Lyophilization, Oral Solid Dose, Oncology Products, Small Molecule API

Compare Fermion with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Fermion
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.